WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

Novartis AG vs Pfizer Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Novartis AG

NOVN · SIX Swiss Exchange

Market cap (USD)$272B
Gross margin (TTM)74.7%
Operating margin (TTM)30.2%
Net margin (TTM)22.5%
SectorHealthcare
IndustryPharmaceuticals
CountryCH
Data as of2026-08-23
56/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Novartis AG's moat claims, evidence, and risks.

View NOVN analysis

Pfizer Inc.

PFE · New York Stock Exchange

Market cap (USD)$159.5B
Gross margin (TTM)73.2%
Operating margin (TTM)21.7%
Net margin (TTM)6.8%
SectorHealthcare
IndustryPharmaceuticals
CountryUS
Data as of2026-08-23
58/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Pfizer Inc.'s moat claims, evidence, and risks.

View PFE analysis

Comparison highlights

  • Moat score gap: Pfizer Inc. leads (58 / 100 vs 56 / 100 for Novartis AG).
  • Segment focus: Novartis AG has 5 segments (31% in Oncology); Pfizer Inc. has 5 segments (37.5% in Primary Care).
  • Moat breadth: Novartis AG has 2 moat types across 2 domains; Pfizer Inc. has 1 across 1.

Primary market context

Novartis AG

Oncology

Market

Oncology and hematology branded medicines (including targeted therapies and radioligand therapy)

Geography

Global

Customer

Oncologists and hospitals; reimbursed by payers; hospital and specialty pharmacy channels

Role

Originator developer, manufacturer, and marketer of oncology therapies

Revenue share

31%

Pfizer Inc.

Primary Care

Market

Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)

Geography

Global

Customer

Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement

Role

Innovator biopharma (R&D + manufacturing + commercialization)

Revenue share

37.5%

Side-by-side metrics

Novartis AG
Pfizer Inc.
Ticker / Exchange
NOVN - SIX Swiss Exchange
PFE - New York Stock Exchange
Market cap (USD)
$272B
$159.5B
Gross margin (TTM)
74.7%
73.2%
Operating margin (TTM)
30.2%
21.7%
Net margin (TTM)
22.5%
6.8%
Sector
Healthcare
Healthcare
Industry
Pharmaceuticals
Pharmaceuticals
HQ country
CH
US
Primary segment
Oncology
Primary Care
Market structure
Oligopoly
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
56 / 100
58 / 100
Moat domains
Legal, Supply
Legal
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

IP Choke Point

Novartis AG strengths

Capex Knowhow Scale

Pfizer Inc. strengths

No unique moat types yet.

Segment mix

Novartis AG segments

Full profile >

Cardiovascular, Renal and Metabolic

Oligopoly

12.6%

Immunology

Oligopoly

19.1%

Neuroscience

Oligopoly

12.5%

Oncology

Oligopoly

31%

Established Brands

Competitive

24.9%

Pfizer Inc. segments

Full profile >

Primary Care

Oligopoly

37.5%

Specialty Care

Oligopoly

21.3%

Oncology

Competitive

27.1%

Hospital and Biosimilars

Competitive

11.9%

Pfizer CentreOne

Competitive

2.2%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.